홈 › 급성 골수성 백혈병 › 버지니아 › Charlottesville
VA Charlottesville의 급성 골수성 백혈병 임상 시험
급성 골수성 백혈병 관련 연구 16개가 Charlottesville 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
피험자 모집 중2상
- University of Virginia Cancer Center, Charlottesville
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
피험자 모집 중2상
- University of Virginia Cancer Center, Charlottesville
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
피험자 모집 중2상
- University of Virginia Cancer Center, Charlottesville
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
피험자 모집 중2상
- University of Virginia Cancer Center, Charlottesville
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
피험자 모집 중3상
- University of Virginia Cancer Center, Charlottesville
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
피험자 모집 중3상
- University of Virginia Cancer Center, Charlottesville
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
피험자 모집 중1/2상
- University of Virginia Cancer Center, Charlottesville
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
피험자 모집 중3상
- University of Virginia School of Medicine, Charlottesville
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
피험자 모집 중1상
- University of Virginia Comprehensive Cancer Center, Charlottesville
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
피험자 모집 중관찰 연구
- University of Virginia, Charlottesville
Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS
피험자 모집 중1상
- University of Virginia, Charlottesville
Cardioprotection in AML
피험자 모집 중2상
- University of Virginia, Charlottesville
A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
피험자 모집 중1/2상
- University of Virginia, Charlottesville
Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
피험자 모집 중1상
- University of Virginia Cancer Center, Charlottesville
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
피험자 모집 중1/2상
- University of Virginia, Charlottesville
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
피험자 모집 중2상
- University of Virginia, Charlottesville
다른 도시의 급성 골수성 백혈병 시험
- Houston, TX연구 85개
- New York City, NY연구 51개
- Boston, MA연구 44개
- Baldwin Park, CA연구 40개
- Seattle, WA연구 40개
- Columbus, OH연구 35개
- Philadelphia, PA연구 34개
- Durham, NC연구 33개
- Atlanta, GA연구 30개
- Tampa, FL연구 29개
- Chicago, IL연구 26개
- Portland, OR연구 25개
Charlottesville의 다른 연구
- 비소세포폐암연구 21개
- 전립선암연구 15개
- 전이성 암연구 13개
- 자궁내막암연구 13개
- 암 (전체)연구 13개
- 폐암연구 13개
- 심부전연구 11개
- 난소암연구 10개
- 대장직장암연구 10개
- 제1형 당뇨병연구 9개
- 유방암연구 9개
- 췌장암연구 9개
ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.